Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis

Amanda B. Payne, Janet A. Watts, Patrick K. Mitchell, Kristin Dascomb, Stephanie A. Irving, Nicola P. Klein, Shaun J. Grannis, Toan C. Ong, Sarah Ball, Malini B. DeSilva, Karthik Natarajan, Tamara Sheffield, Daniel Bride, Julie Arndorfer, Allison L. Naleway, Pradeep Koppolu, Bruce Fireman, Ousseny Zerbo, Julius Timbol, Kristin Goddard, Brian E. Dixon, William F. Fadel, Colin Rogerson, Katie Allen, Suchitra Rao, David Mayer, Michelle A. Barron, Sarah E. Reese, Elizabeth Rowley, Morgan Najdowski, Allison Avrich Ciesla, Josephine Mak, Emily Reeves, Omobosola Akinsete, Charlene McEvoy, Inih Essien, Mark W. Tenforde, Katherine E. Fleming-Dutra, Ruth Link‐Gelles